Correction to “Risk of Heart Failure Hospitalization Associated With Hypoxia‐Inducible Factor Prolyl Hydroxylase Inhibitors Versus Erythropoiesis‐Stimulating Agents: A Nationwide Claims‐Based Cohort Study”

Pharmacoepidemiology and Drug Safety · Wiley · 2026-11-11 · DOI: 10.1002/pds.70522

Аннотация

Pharmacoepidemiology and Drug Safety, Volume 35, Issue 11, November 2026.

Читать у издателя →

Похожие статьи